Extended Data Table 2 |.

Demographic information for the 43 patients with PD and 43 patients with MSA whose CSF samples were used to characterize amplified α-syn aggregates in detail

Parkinson’s Disease (PD)				Multiple System Atrophy (MSA)
S/No	Clinical Diagnosis	Age/Sex	Disease Duration	S/No	Clinical Diagnosis	Age/Sex	Disease Duration
1	PD	71/F	11	1	MSA-P	61/M	2
2	PD	61/M	8	2	MSA-C	60/M	6
3	PD	59/F	12	3	MSA-C	61/M	5
4	PD	63/F	7	4	MSA-C	66/F	3
5	PD	66/F	8	5	MSA-C	58/M	7
6	PD	62/M	8	6	MSA-C	53/M	2
7	PD	72/M	17	7	MSA-C	65/F	2
8	PD	69/M	12	8	MSA-P	55/M	3
9	PD	67/M	15	9	MSA-P	64/M	1
10	PD	58/F	8	10	MSA-C	60/M	6
11	PD	66/M	6	11	MSA-C	63/M	1
12	PD	74/F	6	12	MSA-C	51/M	2.5
13	PD	73/F	5	13	MSA-P	59/F	2
14	PD	61/F	9	14	MSA-C	54/M	6
15	PD	69/M	5	15	MSA-P	49/F	3
16	PD	65/M	7	16	MSA-C	55/M	3
17	PD	69/F	11	17	MSA-C	68/M	5
18	PD	65/M	10	18	MSA-C	56/F	1.5
19	PD	68/M	N/A	19	MSA-C	57/F	2.5
20	PD	57/F	N/A	20	MSA-C	59/M	1
21	PD	71/F	N/A	21	MSA-C	49/M	1
22	PD	68/M	N/A	22	MSA-C	50/M	2
23	PD	79/M	N/A	23	MSA-P	54/M	5
24	PD	68/M	21	24	MSA-P	64/M	3
25	PD	70/M	1	25	MSA-C	68/F	6
26	PD	62/M	3	26	MSA-C	60/M	2
27	PD	63/M	10	27	MSA-C	61/M	1
28	PD	74/M	17	28	MSA-C	62/M	2
29	PD	69/M	6	29	MSA-P	53/M	4
30	PD	66/M	5	30	MSA-P	54/M	5
31	PD	73/F	15	31	MSA-C	61/M	8
32	PD	54/M	6	32	MSA-C	66/F	3
33	PD	71/M	5	33	MSA-C	54/M	4
34	PD	72/M	5	34	MSA-C	62/M	9
35	PD	74/M	5	35	MSA-C	48/F	5
36	PD	59/M	15	36	MSA-P	54/F	2
37	PD	53/F	4	37	MSA-P	60/F	2
38	PD	73/M	N/A	38	MSA-P	73/F	10
39	PD	69/F	N/A	39	MSA-P	57/F	2.5
40	PD	47/M	N/A	40	MSA-C	68/F	3.5
41	PD	59/M	N/A	41	MSA-C	52/M	12
42	PD	61/F	24	42	MSA-C	58/M	5
43	PD	68/M	12	43	MSA-C	54/M	3

Age and disease duration are given in years. MSA-C, MSA with cerebellar ataxia; MSA-P, MSA with Parkinsonism.